Abstract:The application of CRISPR interference (CRISPRi) and CRISPR activation (CRISPRa) technologies in zebrafish has the potential to expand its capacity for the study of gene function significantly. We have developed a codon optimized CRISPRi/a for zebrafish; here we provide proof-of-principle data across established pigmentary and growth phenotypes. We established a zebrafish codon-optimized cas9 gene, harboring mutations D10A and D839A to render the protein catalytically inactive ( ). Similarly, codon-optimized Krüppel associated box (KRAB) and methylated CP2 (MeCP2) inactivating domains or VP64 activator domain were cloned downstream from for CRISPRi and CRISPRa, respectively. To validate CRISPRi, we targeted key genes in melanocyte differentiation ( and ); and melanin production (tyrosinase; ). Microinjection of CRISPRi mRNA and single guide RNAs (sgRNAs) targeting the promoter or 5′-UTR resulted in larvae with hypopigmented epidermal melanocytes. Transcription factors mitfa and mitfb similarly direct differentiation and pigmentation of epidermal melanocytes ( ) and retinal pigment epithelium (RPE, ). CRISPRi-mediated targeting of their promoters or 5′-UTR also results in pronounced hypopigmentation of epidermal melanocytes ( ), and RPE ( ). So too, targeting CRISPRi to the promoter results in hypopigmentation of both epidermal melanocytes and RPE consistent with its role upstream of and , and . Finally, we asked whether CRISPRi and CRISPRa could be used to modulate a single gene, to yield hypomorphic and hypermorphic effects, selecting , as our target. This gene regulates energy homeostasis and somatic growth via inhibition of the melanocortin 4 receptor gene ( ). We demonstrate that targeting the 5′-UTR with CRISPRa or CRISPRi significantly increases or decreases larval body length, respectively. We demonstrate the utility of CRISPRi/a for modulating control of zebrafish gene expression, facilitating efficient assay of candidate gene function and disease relevance.

Ubiquitous and Tissue-specific RNA Targeting in Drosophila Melanogaster Using CRISPR/CasRx

Programmable RNA Targeting Using CasRx in Flies

Various applications of TALEN- and CRISPR/Cas9-mediated homologous recombination to modify the Drosophila genome.

Targeted Gene Disruption by CRISPR/xCas9 System in Drosophila Melanogaster.

Transcriptome Engineering with RNA-Targeting Type VI-D CRISPR Effectors

Optimized CRISPR/Cas tools for efficient germline and somatic genome engineering in Drosophila

A Small-Molecule Approach to Restore Female Sterility Phenotype Targeted by a Homing Suppression Gene Drive in the Fruit Pest Drosophila Suzukii

Optimized Strategy for in Vivo Cas9-activation in Drosophila

Precise transcript targeting by CRISPR-Csm complexes

Enhanced RNA-targeting CRISPR-Cas technology in zebrafish

Enhanced Specificity and Efficiency of the CRISPR/Cas9 System with Optimized Sgrna Parameters in Drosophila

Cytosolic CRISPR RNA for RNA-targeting CRISPR-Cas systems

A Drosophila CRISPR/Cas9 Toolkit for Conditionally Manipulating Gene Expression in the Prothoracic Gland As a Test Case for Polytene Tissues

Enhanced specificity and efficiency of the CRISPR/Cas9 system with optimized sgRNA parameters in Drosophila.

Next generation CRISPR/Cas9 transcriptional activation in<i>Drosophila</i>using flySAM

Comparing robotic and manual injection methods in zebrafish embryos for high-throughput RNA silencing using CRISPR-RfxCas13d

A CRISPR/RfxCas13d-mediated strategy for efficient RNA knockdown in mouse embryonic development

Specific Modulation of CRISPR Transcriptional Activators through RNA-Sensing Guide RNAs in Mammalian Cells and Zebrafish Embryos

CRISPRs for Optimal Targeting: Delivery of CRISPR Components as DNA, RNA, and Protein into Cultured Cells and Single-Cell Embryos

Next-Generation Crispr/Cas9 Transcriptional Activation In Drosophila Using Flysam

Optimized CRISPR inhibition and activation opens key avenues for systematic biological exploration in zebrafish.